FindTrial
Sign In

Effects of dexmedetomidine on postoperative agitation in patients undergoing craniocerebral surgery: feature extraction and small sample learning

Comparison of propofol combined with dexmedetomidine and remifentanil in ultrasound gastroenteroscopy: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057191
Enrollment
Unknown
Registered
2022-03-02
Start date
2022-03-07
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurological disorder

Interventions

Observation group:dexmedetomidine
Control group:normal saline

Sponsors

Shandong Cancer Institute, Shandong Cancer Hospital, Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with craniocerebral tumors who need surgery, aged 18-80 years; 2. ASA: I-II; 3. Able to complete all clinical data.

Exclusion criteria

Exclusion criteria: 1. Complicated with central nervous system disease or craniocerebral injury; 2. Complicated with hypertension, coronary heart disease, abnormal cardiac conduction, and major organ diseases; 3. Blood coagulation or immune system diseases; 4. History of drug abuse, etc.

Design outcomes

Primary

MeasureTime frame
cerebral oxygen uptake ;arterial-internal jugular vein bulb oxygen difference;post-awakening agitation scores;—

Secondary

MeasureTime frame
mean arterial pressure;heart rate;—

Countries

China

Contacts

Public ContactWang Xiuqin

Shandong Cancer Institute, Shandong Cancer Hospital, Shandong First Medical University

jasmine75@163.com+86 13665416586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026